홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
TRVI
#2046
Trevi Therapeutics, Inc. Common Stock
14.0
4
USD
+5.33%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+5.33%
월간 변동
+25.25%
6달 변화
+36.31%
년간 변동율
+131.68%
이전 종가
13.3
3
Open
14.0
4
Bid
Ask
Low
14.0
4
High
14.0
4
양
100
마켓
주식
헬스케어
TRVI
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
19.91 M
30.81 M
60.05 M
68.96 M
96.68 M
128.4 M
—
Valuation ratios
Enterprise value
17.4 M
1.9 M
118.48 M
57.25 M
364.23 M
1.59 B
3.87 B
Price to earnings ratio
—
—
-4.51
-4.48
-8.77
-39.13
-90.86
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
—
—
-4.65
-4.06
-10.98
-40.08
-96.03
Price to book ratio
—
—
1.22
1.56
4.22
9.21
14.62
EBITDA 비율에 대한 기업 가치
—
—
-3.62
-1.69
-7.09
-32.3
-76.98
Profitability ratios
Return on assets %
-0.7
-0.88
-0.24
-0.33
-0.43
-0.22
-0.26
Return on equity %
-1.2
-1.99
-0.27
-0.35
-0.48
-0.23
-0.27
Return on invested capital %
-17.06 K
-3 434.49
-1 705.77
-2 827.93
-10.51 K
-10.24 K
-12.68 K
Gross margin %
—
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.33
2.98
9.15
15.03
10.41
19.66
79.4
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
0
0
0
0
0
Solvency ratios
Debt to assets ratio
0.3
0.38
0.07
—
—
—
—
Debt to equity ratio
0.52
0.86
0.09
—
—
—
—
Long term debt to total assets ratio
0.3
0.38
0.07
—
—
—
—
Long term debt to total equity ratio
0.51
0.85
0.09
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-0.44
-0.32
-0.38
-0.31
-0.32
EBIT per share
—
—
-0.46
-0.34
-0.51
-0.37
-0.37
EBITDA per share
—
—
-0.47
-0.34
-0.5
-0.37
-0.37
Total debt per share
—
—
0.14
—
—
—
—
Cash per share
—
—
1.87
0.84
1.06
1.4
5.18
Net current asset value per share
—
—
1.9
0.88
1.07
1.42
5.28
Tangible book value per share
—
—
1.66
0.83
0.98
1.36
5.04
Working capital per share
—
—
1.69
0.83
0.97
1.35
5.01
Book value per share
—
—
1.66
0.83
0.98
1.36
5.04
뉴스
Trevi Therapeutics, Inc. (TRVI) Q4 2025 Earnings Call Transcript
Zacks.com featured highlights include Trevi, Metalla Royalty & Streaming and Vermilion
Trevi Therapeutics, 오펜하이머, 3상 계획에 지지
Trevi Therapeutics stock gets Oppenheimer nod on Phase 3 plans
Up Over 50%: 3 Stocks on the Verge of a Massive Breakout in March
트레비, IPF 만성 기침 치료제 3상 임상 두 건 계획
Trevi plans two phase 3 trials for chronic cough treatment in IPF
Does Trevi Therapeutics (TRVI) Have the Potential to Rally 102.07% as Wall Street Analysts Expect?
트레비, 날부핀 ER, IPF 기침 감소 효과 입증
Trevi’s nalbuphine ER shows significant reduction in IPF cough
트레비 테라퓨틱스, 만성 기침 치료제 FDA 미팅 예정
Trevi Therapeutics schedules FDA meeting for chronic cough program